Seeking Alpha

zorbs99

zorbs99
Send Message
ABOUT
20 years in parma sales. Like to follow and invest in value pharma stocks at the bottom.
SNAPSHOT
  • Description: Occasional Investor. Trading frequency: Infrequent
  • Interests: Retirement savings, Stocks - long
COMPANY
Currently, there is no company profile for zorbs99.
Blog
Currently, there are no blog details for zorbs99.
BOOK
Currently, there are no book details for zorbs99.
LATEST STOCKTALK more »
Celldex therapeutics. In at $5 and hope to see its deep pipeline grow into a multi billion marketcap company. Apr 27, 2013